Heya Luan

45 Changchun Street
Beijing, 100053, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Serial failure of the brain clearance continuum in Alzheimer's disease: mechanisms and therapeutic perspectives.

Serial failure of the brain clearance continuum in Alzheimer's disease: mechanisms and therapeutic perspectives.

Journal: Journal of neurology

Published: April 25, 2026

Alterations in choroid plexus volume associated with butylphthalide treatment in mild cognitive impairment: Data from a randomized, placebo-controlled study.

Alterations in choroid plexus volume associated with butylphthalide treatment in mild cognitive impairment: Data from a randomized, placebo-controlled study.

Journal: Journal of Alzheimer's disease : JAD

Published: April 23, 2026

Neuronal autoantibodies in neurodegenerative dementia: From evidence to clinical framework.

Neuronal autoantibodies in neurodegenerative dementia: From evidence to clinical framework.

Journal: The journal of prevention of Alzheimer's disease

Published: November 10, 2025

Plasma myeloperoxidase predicts cognitive decline in mild cognitive impairment: a multicenter longitudinal cohort study.

Plasma myeloperoxidase predicts cognitive decline in mild cognitive impairment: a multicenter longitudinal cohort study.

Journal: The journals of gerontology. Series A, Biological sciences and medical sciences

Published: November 03, 2025

Neuronal Surface and Intracellular Antibodies in Mild Cognitive Impairment Due to Alzheimer Disease: Preserved Brain Metabolism on 18F-FDG-PET.

Neuronal Surface and Intracellular Antibodies in Mild Cognitive Impairment Due to Alzheimer Disease: Preserved Brain Metabolism on 18F-FDG-PET.

Journal: AJNR. American journal of neuroradiology

Published: August 18, 2025

Cognitive Function and Proteomic Changes in Patients with Autoantibody-Positive Neurodegenerative Dementia.

Cognitive Function and Proteomic Changes in Patients with Autoantibody-Positive Neurodegenerative Dementia.

Journal: Neurology and therapy

Published: July 09, 2025

Autoantibodies in Alzheimer's disease: Multifaceted roles and therapeutic horizons.

Autoantibodies in Alzheimer's disease: Multifaceted roles and therapeutic horizons.

Journal: Journal of Alzheimer's disease : JAD

Published: June 23, 2025

The disease burden, risk factors and future predictions of Alzheimer's disease and other types of dementia in Asia from 1990 to 2021.

The disease burden, risk factors and future predictions of Alzheimer's disease and other types of dementia in Asia from 1990 to 2021.

Journal: The journal of prevention of Alzheimer's disease

Published: January 27, 2025

Nutrition: A non-negligible factor in the pathogenesis and treatment of Alzheimer's disease.

Nutrition: A non-negligible factor in the pathogenesis and treatment of Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: November 14, 2024

Structural and metabolic topological alterations associated with butylphthalide treatment in mild cognitive impairment: Data from a randomized, double-blind, placebo-controlled trial.

Structural and metabolic topological alterations associated with butylphthalide treatment in mild cognitive impairment: Data from a randomized, double-blind, placebo-controlled trial.

Journal: Psychiatry and clinical neurosciences

Published: October 16, 2024

Characteristics and Transcriptomic Analysis of Cholinergic Neurons Derived from Induced Pluripotent Stem Cells with APP Mutation in Alzheimer's Disease.

Characteristics and Transcriptomic Analysis of Cholinergic Neurons Derived from Induced Pluripotent Stem Cells with APP Mutation in Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: August 30, 2024

Efficacy and safety of butylphthalide in patients with mild cognitive impairment: a multicentre, randomised, double-blind, placebo-controlled trial (EBMCI study).

Efficacy and safety of butylphthalide in patients with mild cognitive impairment: a multicentre, randomised, double-blind, placebo-controlled trial (EBMCI study).

Journal: BMJ open

Published: July 13, 2024

Showing 1-12 of 18

Last Updated: 09/26/2026